Question for the HER2support crew at ASCO
 

Could you find out if there any presentation or report or information discussing whether raloxifene has demonstrated the same resistance problems that tamoxifen has, now that raloxifene has shown its effectiveness?

Because tamoxifen has such a long history and has been the drug of choice for premenopausal HR+ patients, it still seems to be accepted as the only option -- but does this make any sense in terms of HR+ HER2's?

AlaskaAngel

If I may,I would like to add an other question to that of AlaskaAngel for those attending ASCO:

any clinical trial results comparing Herceptin alone versus Herceptin+aromatase inhibitor? (or failing that, any comment from experts on the pros & cons of the combo)

Herceptin is reported to block FAS activity.


Does Herceptin block manifacture of longer chain fats.

Omega 3 including DHA and EPA

Omega six incudng Arachnidonic acid

In breast only.

In whole body.

In whole body except brain.